Global Medical Imaging Contrast Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Medical Imaging Contrast Market Insights, Forecast to 2034
Medical imaging contrast refers to substances or agents used to enhance the visibility and differentiation of structures or regions within the body during various medical imaging procedures. These substances increase the contrast between different tissues or fluids, allowing healthcare professionals to obtain clearer and more detailed images, aiding in diagnosis, treatment planning, and monitoring of medical conditions.
Examples include iodine-based agents for X-rays and CT scans, gadolinium-based agents for MRI, barium sulfate for GI tract X-rays, and microbubble agents for ultrasound.
Contrast agents can be administered orally, intravenously, or through other routes, depending on the imaging modality and the specific area of the body being examined. They work by altering the way X-rays, magnetic resonance (MR) signals, or ultrasound waves interact with different tissues, resulting in better visualization of anatomical structures or pathological changes.
Global Medical Imaging Contrast market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Medical Imaging Contrast industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Medical Imaging Contrast key manufacturers include Bayer, Guerbet Group, Bracco Imaging, GE Healthcare, BeiLu Pharma, Hengrui Medicine, Lantheus and YRPG, etc. Bayer, Guerbet Group, Bracco Imaging are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Medical Imaging Contrast were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Medical Imaging Contrast market and estimated to attract more attentions from industry insiders and investors.
Medical Imaging Contrast can be divided into Iodine-based Agents, Gadolinium-based Agents, Barium Sulfate and Others, etc. Iodine-based Agents is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Medical Imaging Contrast is widely used in various fields, such as Hospitals and Clinics, etc. Hospitals provides greatest supports to the Medical Imaging Contrast industry development. In 2022, global % sales of Medical Imaging Contrast went into Hospitals filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Medical Imaging Contrast market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Medical Imaging Contrast market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
Bayer
Guerbet Group
Bracco Imaging
GE Healthcare
BeiLu Pharma
Hengrui Medicine
Lantheus
YRPG
Segment by Type
Iodine-based Agents
Gadolinium-based Agents
Barium Sulfate
Others
Hospitals
Clinics
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Medical Imaging Contrast plant distribution, commercial date of Medical Imaging Contrast, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Medical Imaging Contrast introduction, etc. Medical Imaging Contrast Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Medical Imaging Contrast
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Examples include iodine-based agents for X-rays and CT scans, gadolinium-based agents for MRI, barium sulfate for GI tract X-rays, and microbubble agents for ultrasound.
Contrast agents can be administered orally, intravenously, or through other routes, depending on the imaging modality and the specific area of the body being examined. They work by altering the way X-rays, magnetic resonance (MR) signals, or ultrasound waves interact with different tissues, resulting in better visualization of anatomical structures or pathological changes.
Global Medical Imaging Contrast market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Medical Imaging Contrast industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Medical Imaging Contrast key manufacturers include Bayer, Guerbet Group, Bracco Imaging, GE Healthcare, BeiLu Pharma, Hengrui Medicine, Lantheus and YRPG, etc. Bayer, Guerbet Group, Bracco Imaging are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Medical Imaging Contrast were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Medical Imaging Contrast market and estimated to attract more attentions from industry insiders and investors.
Medical Imaging Contrast can be divided into Iodine-based Agents, Gadolinium-based Agents, Barium Sulfate and Others, etc. Iodine-based Agents is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Medical Imaging Contrast is widely used in various fields, such as Hospitals and Clinics, etc. Hospitals provides greatest supports to the Medical Imaging Contrast industry development. In 2022, global % sales of Medical Imaging Contrast went into Hospitals filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Medical Imaging Contrast market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Medical Imaging Contrast market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Bayer
Guerbet Group
Bracco Imaging
GE Healthcare
BeiLu Pharma
Hengrui Medicine
Lantheus
YRPG
Segment by Type
Iodine-based Agents
Gadolinium-based Agents
Barium Sulfate
Others
Segment by Application
Hospitals
Clinics
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Medical Imaging Contrast plant distribution, commercial date of Medical Imaging Contrast, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Medical Imaging Contrast introduction, etc. Medical Imaging Contrast Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Medical Imaging Contrast
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports